Exosomes carrying anti-miR-221 and gemcitabine curb pancreatic cancer growth
Pancreatic ductal adenocarcinoma remains one of the most formidable opponents in clinical oncology, a disease so aggressive and so resistant ...
Pancreatic ductal adenocarcinoma remains one of the most formidable opponents in clinical oncology, a disease so aggressive and so resistant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine